Who Ever Said It Would Be Easy? Reflecting on Two Clinical Trials Targeting α-Synuclein

Viewpoint with my clinical colleague’s professor Michael G. Schlossmacher and professor Leonidas Stefanis where we discuss the two recent clinical anti-alpha-synuclein vaccination trials and possible ways to move forward.